Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学MET Amplification, METex14

Paul Paik

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Thoracic Medical Oncologist

48
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Paul Paik is a thoracic oncologist at MSK with a specialized focus on MET-driven lung cancers including MET exon 14 skipping mutations and MET amplification. He has been a principal investigator in major METex14 trials and has contributed to the understanding of MET copy number thresholds that predict response to MET inhibitors. His work on MET FISH and NGS testing strategies has shaped clinical biomarker selection.

Share:

🧪Research Fields 研究领域

METex14 skipping mutations
capmatinib tepotinib METex14
MET amplification testing
lung cancer molecular profiling
MET high-level amplification

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Paul Paik 的研究动态

Follow Paul Paik's research updates

留下邮箱,当我们发布与 Paul Paik(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment